Michael Davis becomes Cyanotech chairman

Hawaiian microalgae technology company looks forward to continuing support of its major shareholder

Michael Davis has been elected as chairman of Hawaii-based Cyanotech Corporation. He replaces Gregg Robertson, who resigned in late 2010.

Davis was vice-chairman of the board and has been a director of Cyanotech since March 2003.

‘Michael has been a key influence in helping Cyanotech sharpen its business model and market focus in recent years,’ said Brent Bailey, president and ceo. ‘We look forward to his continuing support and leadership as chairman of the board.’

Cyanotech Corporation, a microalgae technology specialist, produces BioAstin Natural Astaxanthin and Hawaiian Spirulina Pacifica, which are natural, functional nutrients.

You may also like

Ingredients

CPHI 2025: BENEO to present galenIQ as the granulation binder of choice

At this year’s CPHI Europe in Frankfurt (28–30 October), BENEO will showcase the latest advancements in granulation with its pharmaceutical-grade isomalt excipient: galenIQ
Ingredients

FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars

The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs
Ingredients

Lubrizol to showcase game-changing excipients and nutraceutical ingredients at CPHI Frankfurt

Lubrizol partners with pharmaceutical and nutraceutical companies to develop innovative solutions that improve patient outcomes and offer consumer benefits
Ingredients

Debunking the myths of HPMC adoption

Adopting new products, formulations and ways of working can be a challenge for industries as regulated as pharmaceuticals, writes Dr Subhashis Chakraborty, General Manager, Head of Global Product Management, at ACG Capsules
Ingredients

Meet Navetta: new approach to safety testing of drugs and particles

Turn inhalation research upside down
Ingredients

Shimadzu’s new UV-1900i Plus – smarter, faster UV-Vis spectrophotometer

Next-generation model offers ultra-fast scans and versatile measurement modes
Ingredients

IMCD bolsters API portfolio with Trichem Healthcare acquisition

This acquisition will bolster IMCD's portfolio of specialty pharmaceutical ingredients
Subscribe now